Restricted Research - Award List, Note/Discussion Page
Fiscal Year: 2023
1238 University of Houston (143126)
Principal Investigator: Guo,Bin
Total Amount of Contract, Award, or Gift (Annual before 2011): $ 400,000
Exceeds $250,000 (Is it flagged?): Yes
Start and End Dates: 7/1/22 - 6/30/24
Restricted Research: YES
Academic Discipline: Pharmacy
Department, Center, School, or Institute: Pharmacological and Pharmaceutical Sciences
Title of Contract, Award, or Gift: A NOVEL INTERLEUKIN-15 RECEPTOR ANTAGONIST FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
Name of Granting or Contracting Agency/Entity:
Rheumatology Research Foundation
CFDA: 0
Program Title: n/a
Note:
Develop a new and effective RA therapy. The specific aims are 1. Determine the therapeutic efficacy of IFRA3Q1 in murine models of human RA; 2. Optimize the anti-inflammatory efficacy of IFRA3Q1 for arthritic therapy using medicinal chemistry. SAMs 1.1.1
Discussion: No discussion notes